Airway ultrasound in head and neck cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, observational cohort study will compare ultrasound measurements of the airway (distance from skin to epiglottis and to the hyoid) with CT-derived measurements in adults with oncologic head and neck disease undergoing elective surgery under general anesthesia. Measurements are taken preoperatively by trained clinicians using a standardized protocol, and CT measurements are obtained from existing preoperative scans. The study will also explore how these ultrasound measurements relate to clinical airway characteristics and perioperative airway management, including tracheal intubation difficulty and mask ventilation difficulty. Primary analysis focuses on agreement between ultrasound and CT DSE measurements, with DSHB as a secondary outcome.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adults aged 18 years or older.
2. Patients with oncologic disease of the maxillofacial or head and neck region. 3. Patients scheduled for elective surgery under general anesthesia with planned airway management requiring tracheal intubation.

4\. Availability of a preoperative CT examination suitable for the predefined airway measurements.

5\. Written informed consent to participate.

Exclusion Criteria:

1. Age below 18 years.
2. Emergency surgery.
3. Inability to obtain interpretable ultrasound measurements.
4. CT images unsuitable for the predefined anatomical measurements.
5. Refusal to participate or inability to provide informed consent.

Where it's running

• Universitiy Hospital Dubrava
  Zagreb, City of Zagreb, Croatia Recruiting
• University Hospital Dubrava
  Zagreb, City of Zagreb, Croatia Recruiting

Study contacts

• Study coordinator: Marcela Čučković
• Email: mmarcec@kbd.hr
• Phone: 38512902444

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer

  In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.

  Recruiting Phase 2 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Shanghai, Shanghai Municipality · NCT07882888

• SumMET: Targeted radioligand therapy for c-MET–positive solid tumors

  This first‑in‑human study tests the safety and potential effectiveness of a radioligand therapy called [225Ac]Ac-FL-261 in adults with advanced or metastatic solid tumors that overexpress c-MET.

  Recruiting at 2 sites Phase 1/2 Full-Life Technologies UK Limited · Minneapolis, Minnesota and 1 other locations · NCT07873450

• Using Silverlon for head and neck patients with tracheostomies

  This early-phase study tests whether Silverlon dressings can prevent severe skin reactions under tracheostomy collars in adults with head and neck cancer.

  Recruiting Phase 1 State University of New York - Upstate Medical University · Syracuse, New York · NCT07856732

• BNCT for Recurrent Head and Neck Cancer: A 2nd-Phase Trial of AB-BNCT with NBB-001 and NBB-002

  This phase II study tests a boron neutron capture therapy approach combined with NBB-001 and NBB-002 in adults with recurrent head and neck cancer to see if it helps shrink tumors and is safe.

  Recruiting Phase 2 Neuboron Bio-SciTech Co., Ltd. · Xiamen, Fujian · NCT07795034

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.